The disparities in mortality rates are even more pronounced with African-American men experiencing deaths from prostate cancer at a rate that is more than two and half times higher among African-American men compared to Caucasian men (15.3 among Caucasian men, 40.6 among African-American men).
Those who ate dinner earlier and more closely adhered to a healthy lifestyle had a 35 percent decrease change of developing prostate and breast cancer.
According to new research from the United States, a side-effect of a common prostate cancer drug can, in some men with advanced disease who have a specific genetic variant, actually fuel cancer cells.
The FDA has approved the supplemental New Drug Application (sNDA) for enzalutamide (Xtandi) for the treatment of non-metastatic castration-resistant prostate cancer (CRPC), according to a press release. Studies have shown that stress affects health, but little is known about whether stress has an impact on the development of aggressive prostate cancer, Haiman explained.Читайте также: British Open: Tiger Woods shows promising signs in Round 1
Based on data from U.S. Cancer Statistics Working Group - U.S. Cancer Statistics Data Visualizations Tool, based on November 2017 submission data (1999-2015): U.S. Department of Health and Human Services, Centers for Disease Control and Prevention and National Cancer Institute; www.cdc.gov/cancer/dataviz, June 2018. In addition, this study builds on years of research collaboration involving investigators who are part of the African Ancestry Prostate Cancer (AAPC) consortium.
Cancer of the breast and prostate are often associated with the activity of various hormones. The samples will be used to identify genetic markers for prostate cancer and tumor characteristics, with a special emphasis on aggressive prostate cancer. Marinac's own research suggests that eating in tune with the body's natural clock may help reduce the risk of breast cancer recurrence in survivors.
RESPOND, a cooperative agreement, will be led by Christopher Haiman, Sc.D., of the University of Southern California (USC) in Los Angeles, in collaboration with John Carpten, Ph.D., Ann Hamilton, Ph.D., and David Conti, Ph.D., also of USC; Scarlett Gomez, Ph.D., of the University of California, San Francisco; Tamara Lotan, M.D., of Johns Hopkins University in Baltimore; and Franklin Huang, M.D., Ph.D., of Dana-Farber Cancer Institute in Boston. Researchers hope to recruit 10,000 African-American men to participate in the nationwide study.При любом использовании материалов сайта и дочерних проектов, гиперссылка на обязательна.
«» 2007 - 2019 Copyright.
Автоматизированное извлечение информации сайта запрещено.
Код для вставки в блог